EGFR and lung adenocarcinoma: Along with the high frequency of epidermal growth factor receptor (EGFR) activating mutations, the early onset of lung adenocarcinoma (LUAD) among never-smokers in this region is suggestive of a genetic contribution towards disease presentation [17].